Enovis Corporation (ENOV)Healthcare | Medical Devices | Wilmington, United States | NYSE
23.73 USD
-2.54
(-9.669%) ⇩
(April 21, 2026, 4 p.m.
EDT)
After hours: 23.73 Short-term: ★★★★☆ | Long-term: ★★★☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:35 a.m. EDT
While fundamentals remain shaky with negative earnings and a history of no dividends, the risk/reward has shifted drastically in the short term. The stock is trading near its 200-day average after a multi-year downtrend, and the options market is heavily betting on a reversal. The forecast model is slightly bearish, but the options flow suggests speculators believe the 'bottom' is in and momentum will catch a break to test the $45 analyst targets. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.057807 |
| AutoETS | 0.057926 |
| AutoARIMA | 0.057928 |
| AutoTheta | 0.142808 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 45% |
| H-stat | 8.71 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.208 |
| Excess Kurtosis | -0.68 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 39.392 |
| Market Cap | 1,365,401,472 |
| Forward P/E | 5.93 |
| Beta | 1.59 |
| Profit Margins | -52.69% |
| Website | https://www.enovis.com |
As of April 19, 2026, 12:35 a.m. EDT: There is a strong bullish skew in options positioning. For the April expiration, there is massive Open Interest (OI) concentration at strikes significantly above the current price (35 and 40 strikes, representing +33% and +52% distance), while put activity is notably lower. Long-dated calls show builders betting on a move toward the mid-30s (45 strike with +71% distance for Dec exp). Conversely, put positioning is heavily aggregated at lower strikes (below current price) across expirations, but call OI percentage is substantially higher than put OI percentage in long-dated terms, indicating speculative sentiment favors an upside bounce toward targets.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.19466585 |
| Address1 | 2,711 Centerville Road |
| Address2 | Suite 400 |
| All Time High | 129.72461 |
| All Time Low | 9.173838 |
| Ask | 24.12 |
| Ask Size | 100 |
| Audit Risk | 5 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 715,340 |
| Average Daily Volume3 Month | 1,001,952 |
| Average Volume | 1,001,952 |
| Average Volume10Days | 715,340 |
| Beta | 1.591 |
| Bid | 23.23 |
| Bid Size | 200 |
| Board Risk | 1 |
| Book Value | 26.045 |
| City | Wilmington |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 2 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 23.73 |
| Current Ratio | 2.017 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 26.64 |
| Day Low | 23.73 |
| Display Name | Enovis |
| Earnings Call Timestamp End | 1,778,157,000 |
| Earnings Call Timestamp Start | 1,778,157,000 |
| Earnings Timestamp | 1,778,157,000 |
| Earnings Timestamp End | 1,778,157,000 |
| Earnings Timestamp Start | 1,778,157,000 |
| Ebitda | 369,174,016 |
| Ebitda Margins | 0.16422 |
| Eps Current Year | 3.60754 |
| Eps Forward | 3.99895 |
| Eps Trailing Twelve Months | -20.72 |
| Esg Populated | 0 |
| Exchange | NYQ |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 23.482 |
| Fifty Day Average Change | 0.24799919 |
| Fifty Day Average Change Percent | 0.010561246 |
| Fifty Two Week Change Percent | -19.466585 |
| Fifty Two Week High | 37.85 |
| Fifty Two Week High Change | -14.119999 |
| Fifty Two Week High Change Percent | -0.3730515 |
| Fifty Two Week Low | 21.0 |
| Fifty Two Week Low Change | 2.7299995 |
| Fifty Two Week Low Change Percent | 0.12999998 |
| Fifty Two Week Range | 21.0 - 37.85 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,210,253,400,000 |
| Float Shares | 56,329,209 |
| Forward Eps | 3.99895 |
| Forward P E | 5.9340577 |
| Free Cashflow | 104,428,624 |
| Full Exchange Name | NYSE |
| Full Time Employees | 7,802 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.60885 |
| Gross Profits | 1,368,724,992 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.01482 |
| Held Percent Institutions | 1.1726899 |
| Implied Shares Outstanding | 57,539,044 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,649,116,800 |
| Last Split Factor | 581:1000 |
| Long Business Summary | Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware. |
| Long Name | Enovis Corporation |
| Market | us_market |
| Market Cap | 1,365,401,472 |
| Market State | POST |
| Max Age | 86,400 |
| Message Board Id | finmb_617309 |
| Net Income To Common | -1,182,530,944 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,511,550,685 |
| Number Of Analyst Opinions | 11 |
| Open | 26.27 |
| Operating Cashflow | 217,292,992 |
| Operating Margins | 0.033269998 |
| Overall Risk | 1 |
| Payout Ratio | 0.0 |
| Peg Ratio | 3.45 |
| Phone | 302 252 9160 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 23.73 |
| Post Market Time | 1,776,809,519 |
| Previous Close | 26.27 |
| Price Eps Current Year | 6.57789 |
| Price Hint | 2 |
| Price To Book | 0.91111535 |
| Price To Sales Trailing12 Months | 0.6073718 |
| Profit Margins | -0.52687 |
| Quick Ratio | 0.801 |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.33333 |
| Region | US |
| Regular Market Change | -2.54 |
| Regular Market Change Percent | -9.66883 |
| Regular Market Day High | 26.64 |
| Regular Market Day Low | 23.73 |
| Regular Market Day Range | 23.73 - 26.64 |
| Regular Market Open | 26.27 |
| Regular Market Previous Close | 26.27 |
| Regular Market Price | 23.73 |
| Regular Market Time | 1,776,801,602 |
| Regular Market Volume | 872,847 |
| Return On Assets | 0.010930001 |
| Return On Equity | -0.58265996 |
| Revenue Per Share | 39.392 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 2 |
| Shares Outstanding | 57,539,044 |
| Shares Percent Shares Out | 0.1416 |
| Shares Short | 8,148,419 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 8,035,071 |
| Short Name | Enovis Corporation |
| Short Percent Of Float | 0.1689 |
| Short Ratio | 8.66 |
| Source Interval | 15 |
| State | DE |
| Symbol | ENOV |
| Target High Price | 55.0 |
| Target Low Price | 33.0 |
| Target Mean Price | 44.72727 |
| Target Median Price | 45.0 |
| Total Revenue | 2,248,048,896 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -20.72 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 27.6183 |
| Two Hundred Day Average Change | -3.8883 |
| Two Hundred Day Average Change Percent | -0.14078708 |
| Type Disp | Equity |
| Volume | 872,847 |
| Website | https://www.enovis.com |
| Zip | 19,808 |